{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:41:39Z","timestamp":1789429299292,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Antimicrobial peptides are present in animals, plants and microorganisms and play a fundamental role in the innate immune response. Gomesin is a cationic antimicrobial peptide purified from haemocytes of the spider <jats:italic>Acanthoscurria gomesiana<\/jats:italic>. It has a broad-spectrum of activity against bacteria, fungi, protozoa and tumour cells. <jats:italic>Candida albicans<\/jats:italic> is a commensal yeast that is part of the human microbiota. However, in immunocompromised patients, this fungus may cause skin, mucosal or systemic infections. The typical treatment for this mycosis comprises three major categories of antifungal drugs: polyenes, azoles and echinocandins; however cases of resistance to these drugs are frequently reported. With the emergence of microorganisms that are resistant to conventional antibiotics, the development of alternative treatments for candidiasis is important. In this study, we evaluate the efficacy of gomesin treatment on disseminated and vaginal candidiasis as well as its toxicity and biodistribution.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Treatment with gomesin effectively reduced <jats:italic>Candida albicans<\/jats:italic> in the kidneys, spleen, liver and vagina of infected mice. The biodistribution of gomesin labelled with technetium-99 m showed that the peptide is captured in the kidneys, spleen and liver. Enhanced production of TNF-\u03b1, IFN-\u03b3 and IL-6 was detected in infected mice treated with gomesin, suggesting an immunomodulatory activity. Moreover, immunosuppressed and <jats:italic>C. albicans<\/jats:italic>-infected mice showed an increase in survival after treatment with gomesin and fluconazole. Systemic administration of gomesin was also not toxic to the mic<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Gomesin proved to be effective against experimental <jats:italic>Candida albicans<\/jats:italic> infection. It can be used as an alternative therapy for candidiasis, either alone or in combination with fluconazole. Gomesin's mechanism is not fully understood, but we hypothesise that the peptide acts through the permeabilisation of the yeast membrane leading to death and\/or releasing the yeast antigens that trigger the host immune response against infection. Therefore, data presented in this study reinforces the potential of gomesin as a therapeutic antifungal agent in both humans and animals.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2180-12-28","type":"journal-article","created":{"date-parts":[[2012,3,6]],"date-time":"2012-03-06T23:14:02Z","timestamp":1331075642000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Therapeutic use of a cationic antimicrobial peptide from the spider Acanthoscurria gomesianain the control of experimental candidiasis"],"prefix":"10.1186","volume":"12","author":[{"given":"Diego C","family":"Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian E","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle D","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Belmonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bluma","family":"Faintuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Primavera","family":"Borelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos P","family":"Taborda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirlei","family":"Daffre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,3,6]]},"reference":[{"key":"1621_CR1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.0105-2896.2004.0124.x","volume":"198","author":"P Bulet","year":"2004","unstructured":"Bulet P, Stocklin R, Menin L: Anti-microbial peptides: from invertebrates to vertebrates. Immunol Rev. 2004, 198: 169-184. 10.1111\/j.0105-2896.2004.0124.x.","journal-title":"Immunol Rev"},{"issue":"3","key":"1621_CR2","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nrmicro1098","volume":"3","author":"KA Brogden","year":"2005","unstructured":"Brogden KA: Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?. Nat Rev Microbiol. 2005, 3 (3): 238-250. 10.1038\/nrmicro1098.","journal-title":"Nat Rev Microbiol"},{"issue":"7-8","key":"1621_CR3","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1007\/s00018-007-6475-6","volume":"64","author":"N Mookherjee","year":"2007","unstructured":"Mookherjee N, Hancock RE: Cationic host defence peptides: innate immune regulatory peptides as a novel approach for treating infections. Cell Mol Life Sci. 2007, 64 (7-8): 922-933. 10.1007\/s00018-007-6475-6.","journal-title":"Cell Mol Life Sci"},{"issue":"43","key":"1621_CR4","doi-asserted-by":"publisher","first-page":"33464","DOI":"10.1074\/jbc.M001491200","volume":"275","author":"PI Silva Jr","year":"2000","unstructured":"Silva PI, Daffre S, Bulet P: Isolation and characterization of gomesin, an 18-residue cysteine-rich defense peptide from the spider Acanthoscurria gomesiana hemocytes with sequence similarities to horseshoe crab antimicrobial peptides of the tachyplesin family. J Biol Chem. 2000, 275 (43): 33464-33470. 10.1074\/jbc.M001491200.","journal-title":"J Biol Chem"},{"issue":"4","key":"1621_CR5","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1046\/j.0014-2956.2002.02760.x","volume":"269","author":"N Mandard","year":"2002","unstructured":"Mandard N, Bulet P, Caille A, Daffre S, Vovelle F: The solution structure of gomesin, an antimicrobial cysteine-rich peptide from the spider. Eur J Biochem. 2002, 269 (4): 1190-1198. 10.1046\/j.0014-2956.2002.02760.x.","journal-title":"Eur J Biochem"},{"issue":"2","key":"1621_CR6","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/bip.20396","volume":"84","author":"MA Fazio","year":"2006","unstructured":"Fazio MA, Oliveira VX, Bulet P, Miranda MT, Daffre S, Miranda A: Structure-activity relationship studies of gomesin: importance of the disulfide bridges for conformation, bioactivities, and serum stability. Biopolymers. 2006, 84 (2): 205-218. 10.1002\/bip.20396.","journal-title":"Biopolymers"},{"issue":"2","key":"1621_CR7","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/j.1574-6968.2007.00850.x","volume":"274","author":"FM Barbosa","year":"2007","unstructured":"Barbosa FM, Daffre S, Maldonado RA, Miranda A, Nimrichter L, Rodrigues ML: Gomesin, a peptide produced by the spider Acanthoscurria gomesiana, is a potent anticryptococcal agent that acts in synergism with fluconazole. FEMS Microbiol Lett. 2007, 274 (2): 279-286. 10.1111\/j.1574-6968.2007.00850.x.","journal-title":"FEMS Microbiol Lett"},{"key":"1621_CR8","volume-title":"Gomesin: a Powerful Antimicrobial Peptide Isolated from the Brazilian Tarantula Spider Acanthoscurria gomesiana","author":"A Miranda","year":"2008","unstructured":"Miranda A, Miranda MTM, Jouvensal L, Vovelle F, Bulet P, Daffre S: Animal toxins. Gomesin: a Powerful Antimicrobial Peptide Isolated from the Brazilian Tarantula Spider Acanthoscurria gomesiana. Edited by: KERALA. 2008"},{"issue":"1","key":"1621_CR9","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1593\/neo.07885","volume":"10","author":"EG Rodrigues","year":"2008","unstructured":"Rodrigues EG, Dobroff AS, Cavarsan CF, Paschoalin T, Nimrichter L, Mortara RA, Santos EL, Fazio MA, Miranda A, Daffre S, et al: Effective topical treatment of subcutaneous murine B16F10-Nex2 melanoma by the antimicrobial peptide gomesin. Neoplasia. 2008, 10 (1): 61-68. 10.1593\/neo.07885.","journal-title":"Neoplasia"},{"issue":"3","key":"1621_CR10","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.idc.2006.07.004","volume":"20","author":"PG Pappas","year":"2006","unstructured":"Pappas PG: Invasive candidiasis. Infect Dis Clin North Am. 2006, 20 (3): 485-506. 10.1016\/j.idc.2006.07.004.","journal-title":"Infect Dis Clin North Am"},{"issue":"10","key":"1621_CR11","doi-asserted-by":"publisher","first-page":"4675","DOI":"10.1128\/IAI.00083-07","volume":"75","author":"A Cassone","year":"2007","unstructured":"Cassone A, De Bernardis F, Santoni G: Anticandidal immunity and vaginitis: novel opportunities for immune intervention. Infect Immun. 2007, 75 (10): 4675-4686. 10.1128\/IAI.00083-07.","journal-title":"Infect Immun"},{"issue":"3","key":"1621_CR12","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1590\/S0074-02762009000300019","volume":"104","author":"M Prado","year":"2009","unstructured":"Prado M, da Silva MB, Laurenti R, Travassos LR, Taborda CP: Mortality due to systemic mycoses as a primary cause of death or in association with AIDS in Brazil: a review from 1996 to 2006. Mem Inst Oswaldo Cruz. 2009, 104 (3): 513-521. 10.1590\/S0074-02762009000300019.","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"5","key":"1621_CR13","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1590\/S0037-86822003000500010","volume":"36","author":"AL Colombo","year":"2003","unstructured":"Colombo AL, Guimaraes T: Epidemiology of hematogenous infections due to Candida spp. Rev Soc Bras Med Trop. 2003, 36 (5): 599-607. 10.1590\/S0037-86822003000500010.","journal-title":"Rev Soc Bras Med Trop"},{"issue":"12","key":"1621_CR14","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1517\/14656566.2010.493875","volume":"11","author":"V Moudgal","year":"2010","unstructured":"Moudgal V, Sobel J: Antifungals to treat Candida albicans. Expert Opin Pharmacother. 2010, 11 (12): 2037-2048. 10.1517\/14656566.2010.493875.","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"1621_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1128\/CMR.00029-06","volume":"20","author":"MA Pfaller","year":"2007","unstructured":"Pfaller MA, Diekema DJ: Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007, 20 (1): 133-163. 10.1128\/CMR.00029-06.","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"1621_CR16","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1086\/596757","volume":"48","author":"PG Pappas","year":"2009","unstructured":"Pappas PG, Kauffman CA, Andes D, Benjamin DK, Calandra TF, Edwards JE, Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, et al: Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009, 48 (5): 503-535. 10.1086\/596757.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"1621_CR17","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.exppara.2007.01.022","volume":"116","author":"CK Moreira","year":"2007","unstructured":"Moreira CK, Rodrigues FG, Ghosh A, Varotti Fde P, Miranda A, Daffre S, Jacobs-Lorena M, Moreira LA: Effect of the antimicrobial peptide gomesin against different life stages of Plasmodium spp. Exp Parasitol. 2007, 116 (4): 346-353. 10.1016\/j.exppara.2007.01.022.","journal-title":"Exp Parasitol"},{"issue":"8","key":"1621_CR18","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1017\/S0031182009006283","volume":"136","author":"RS Sacramento","year":"2009","unstructured":"Sacramento RS, Martins RM, Miranda A, Dobroff AS, Daffre S, Foronda AS, De Freitas D, Schenkman S: Differential effects of alpha-helical and beta-hairpin antimicrobial peptides against Acanthamoeba castellanii. Parasitology. 2009, 136 (8): 813-821. 10.1017\/S0031182009006283.","journal-title":"Parasitology"},{"issue":"6","key":"1621_CR19","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.jinf.2006.11.017","volume":"54","author":"LP Brion","year":"2007","unstructured":"Brion LP, Uko SE, Goldman DL: Risk of resistance associated with fluconazole prophylaxis: systematic review. J Infect. 2007, 54 (6): 521-529. 10.1016\/j.jinf.2006.11.017.","journal-title":"J Infect"},{"issue":"9","key":"1621_CR20","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1086\/522427","volume":"196","author":"A Lupetti","year":"2007","unstructured":"Lupetti A, Brouwer CP, Bogaards SJ, Welling MM, de Heer E, Campa M, van Dissel JT, Friesen RH, Nibbering PH: Human lactoferrin-derived peptide's antifungal activities against disseminated Candida albicans infection. J Infect Dis. 2007, 196 (9): 1416-1424. 10.1086\/522427.","journal-title":"J Infect Dis"},{"key":"1621_CR21","volume-title":"Eur J Clin Microbiol Infect Dis","author":"E Andr\u00e8s","year":"2011","unstructured":"Andr\u00e8s E: Cationic antimicrobial peptides in clinical development, with special focus on thanatin and heliomicin. Eur J Clin Microbiol Infect Dis. 2011, DOI 10.1007\/s10096-011-1430-8"},{"issue":"13","key":"1621_CR22","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.2165\/00003495-200868130-00002","volume":"68","author":"J das Neves","year":"2008","unstructured":"das Neves J, Pinto E, Teixeira B, Dias G, Rocha P, Cunha T, Santos B, Amaral MH, Bahia MF: Local treatment of vulvovaginal candidosis: general and practical considerations. Drugs. 2008, 68 (13): 1787-1802. 10.2165\/00003495-200868130-00002.","journal-title":"Drugs"},{"issue":"2","key":"1621_CR23","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10156-007-0595-7","volume":"14","author":"CC Lai","year":"2008","unstructured":"Lai CC, Tan CK, Huang YT, Shao PL, Hsueh PR: Current challenges in the management of invasive fungal infections. J Infect Chemother. 2008, 14 (2): 77-85. 10.1007\/s10156-007-0595-7.","journal-title":"J Infect Chemother"},{"issue":"3-4","key":"1621_CR24","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1574-695X.1999.tb01402.x","volume":"26","author":"BJ Kullberg","year":"1999","unstructured":"Kullberg BJ, Netea MG, Vonk AG, van der Meer JW: Modulation of neutrophil function in host defense against disseminated Candida albicans infection in mice. FEMS Immunol Med Microbiol. 1999, 26 (3-4): 299-307. 10.1111\/j.1574-695X.1999.tb01402.x.","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"5595","key":"1621_CR25","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1126\/science.1075565","volume":"298","author":"A Biragyn","year":"2002","unstructured":"Biragyn A, Ruffini PA, Leifer CA, Klyushnenkova E, Shakhov A, Chertov O, Shirakawa AK, Farber JM, Segal DM, Oppenheim JJ, et al: Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science. 2002, 298 (5595): 1025-1029. 10.1126\/science.1075565.","journal-title":"Science"},{"issue":"11","key":"1621_CR26","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1002\/1521-4141(200111)31:11<3131::AID-IMMU3131>3.0.CO;2-G","volume":"31","author":"T Birchler","year":"2001","unstructured":"Birchler T, Seibl R, Buchner K, Loeliger S, Seger R, Hossle JP, Aguzzi A, Lauener RP: Human Toll-like receptor 2 mediates induction of the antimicrobial peptide human beta-defensin 2 in response to bacterial lipoprotein. Eur J Immunol. 2001, 31 (11): 3131-3137. 10.1002\/1521-4141(200111)31:11<3131::AID-IMMU3131>3.0.CO;2-G.","journal-title":"Eur J Immunol"},{"key":"1621_CR27","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/978-1-60761-594-1_20","volume":"618","author":"H Jenssen","year":"2010","unstructured":"Jenssen H, Hancock RE: Therapeutic potential of HDPs as immunomodulatory agents. Methods Mol Biol. 2010, 618: 329-347. 10.1007\/978-1-60761-594-1_20.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"1621_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/153537020322800101","volume":"228","author":"JW Fisher","year":"2003","unstructured":"Fisher JW: Erythropoietin: physiology and pharmacology update. Exp Biol Med (Maywood). 2003, 228 (1): 1-14.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"12","key":"1621_CR29","doi-asserted-by":"publisher","first-page":"4522","DOI":"10.1128\/AAC.00448-08","volume":"52","author":"PM Tavares","year":"2008","unstructured":"Tavares PM, Thevissen K, Cammue BP, Francois IE, Barreto-Bergter E, Taborda CP, Marques AF, Rodrigues ML, Nimrichter L: In vitro activity of the antifungal plant defensin RsAFP2 against Candida isolates and its in vivo efficacy in prophylactic murine models of candidiasis. Antimicrob Agents Chemother. 2008, 52 (12): 4522-4525. 10.1128\/AAC.00448-08.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"1621_CR30","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1128\/IAI.66.6.2486-2493.1998","volume":"66","author":"Y Cho","year":"1998","unstructured":"Cho Y, Turner JS, Dinh NN, Lehrer RI: Activity of protegrins against yeast-phase Candida albicans. Infect Immun. 1998, 66 (6): 2486-2493.","journal-title":"Infect Immun"},{"issue":"3","key":"1621_CR31","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1128\/AAC.48.3.693-715.2004","volume":"48","author":"MD Johnson","year":"2004","unstructured":"Johnson MD, MacDougall C, Ostrosky-Zeichner L, Perfect JR, Rex JH: Combination antifungal therapy. Antimicrob Agents Chemother. 2004, 48 (3): 693-715. 10.1128\/AAC.48.3.693-715.2004.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"1621_CR32","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1128\/AAC.46.2.308-314.2002","volume":"46","author":"M Matsumoto","year":"2002","unstructured":"Matsumoto M, Ishida K, Konagai A, Maebashi K, Asaoka T: Strong antifungal activity of SS750, a new triazole derivative, is based on its selective binding affinity to cytochrome P450 of fungi. Antimicrob Agents Chemother. 2002, 46 (2): 308-314. 10.1128\/AAC.46.2.308-314.2002.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"1621_CR33","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1128\/AAC.01061-07","volume":"52","author":"D Andes","year":"2008","unstructured":"Andes D, Diekema DJ, Pfaller MA, Prince RA, Marchillo K, Ashbeck J, Hou J: In vivo pharmacodynamic characterization of anidulafungin in a neutropenic murine candidiasis model. Antimicrob Agents Chemother. 2008, 52 (2): 539-550. 10.1128\/AAC.01061-07.","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"1621_CR34","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/j.1439-0507.2004.00994.x","volume":"47","author":"M Hamad","year":"2004","unstructured":"Hamad M, Abu-Elteen KH, Ghaleb M: Estrogen-dependent induction of persistent vaginal candidosis in naive mice. Mycoses. 2004, 47 (7): 304-309. 10.1111\/j.1439-0507.2004.00994.x.","journal-title":"Mycoses"},{"issue":"4","key":"1621_CR35","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.nucmedbio.2008.02.005","volume":"35","author":"BL Faintuch","year":"2008","unstructured":"Faintuch BL, Teodoro R, Duatti A, Muramoto E, Faintuch S, Smith CJ: Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies. Nucl Med Biol. 2008, 35 (4): 401-411. 10.1016\/j.nucmedbio.2008.02.005.","journal-title":"Nucl Med Biol"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2180-12-28.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T19:05:55Z","timestamp":1630523155000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/1471-2180-12-28"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,6]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1621"],"URL":"https:\/\/doi.org\/10.1186\/1471-2180-12-28","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,6]]},"assertion":[{"value":"5 September 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"28"}}